News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
707,470 Results
Type
Article (41912)
Company Profile (333)
Press Release (665225)
Section
Business (210165)
Career Advice (2083)
Deals (36583)
Drug Delivery (100)
Drug Development (82849)
Employer Resources (171)
FDA (16490)
Job Trends (15361)
News (355494)
Policy (33833)
Tag
Academia (2574)
Alliances (51185)
Alzheimer's disease (1275)
Approvals (16440)
Artificial intelligence (157)
Bankruptcy (362)
Best Places to Work (11717)
Biotechnology (215)
Breast cancer (191)
Cancer (1390)
Cardiovascular disease (116)
Career advice (1744)
Cell therapy (285)
Clinical research (66233)
Collaboration (495)
Compensation (263)
COVID-19 (2612)
C-suite (110)
Data (1400)
Diabetes (174)
Diagnostics (6255)
Earnings (86577)
Employer resources (149)
Events (112865)
Executive appointments (402)
FDA (17171)
Funding (432)
Gene therapy (206)
GLP-1 (631)
Government (4453)
Healthcare (18876)
Infectious disease (2704)
Inflammatory bowel disease (115)
Interviews (320)
IPO (16616)
Job creations (4052)
Job search strategy (1490)
Layoffs (439)
Legal (8326)
Lung cancer (199)
Lymphoma (100)
Manufacturing (215)
Medical device (13297)
Medtech (13302)
Mergers & acquisitions (20118)
Metabolic disorders (470)
Neuroscience (1606)
NextGen Class of 2024 (6625)
Non-profit (4515)
Northern California (1701)
Obesity (268)
Opinion (207)
Patents (120)
People (58416)
Phase I (20511)
Phase II (29144)
Phase III (21855)
Pipeline (517)
Postmarket research (2652)
Preclinical (8730)
Radiopharmaceuticals (241)
Rare diseases (271)
Real estate (6240)
Regulatory (22511)
Research institute (2359)
Resumes & cover letters (359)
Southern California (1468)
Startups (3712)
United States (15333)
Vaccines (582)
Weight loss (196)
Date
Last 7 days (590)
Last 30 days (2346)
Last 365 days (35718)
2024 (35555)
2023 (40630)
2022 (51797)
2021 (56329)
2020 (54794)
2019 (47401)
2018 (35772)
2017 (33137)
2016 (32663)
2015 (38616)
2014 (32516)
2013 (27632)
2012 (29730)
2011 (30489)
2010 (28499)
Location
Africa (776)
Arizona (202)
Asia (40139)
Australia (6423)
California (3837)
Canada (1455)
China (311)
Colorado (174)
Connecticut (179)
Europe (85475)
Florida (535)
Georgia (135)
Illinois (394)
Indiana (232)
Maryland (633)
Massachusetts (3007)
Michigan (174)
Minnesota (291)
New Jersey (1117)
New York (1086)
North Carolina (760)
Northern California (1701)
Ohio (146)
Pennsylvania (929)
South America (1157)
Southern California (1468)
Texas (557)
Utah (109)
Washington State (406)
707,470 Results for "cumberland pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Cumberland Pharmaceuticals to Announce First Quarter 2024 Financial Results
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, announced that it will release its first quarter 2024 financial results and provide a company update after the market closes on Tuesday, May 7, 2024.
April 30, 2024
·
2 min read
Business
Cumberland Pharmaceuticals Reports First Quarter 2024 Financial Results & Company Update
Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, today announced that its product portfolio of FDA-approved brands delivered combined revenues of $8.5 million during the first quarter of 2024.
May 7, 2024
·
21 min read
Business
Cumberland Pharmaceuticals to Announce Annual 2023 Financial Results
Cumberland Pharmaceuticals Inc., a specialty pharmaceuticals company, announced that it will release its annual 2023 financial results and provide a company update after the market closes on Tuesday, March 5, 2024.
February 27, 2024
·
2 min read
Cumberland Pharmaceuticals Reports Annual 2023 Financial Results
Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, announced today that its product portfolio of FDA-approved brands delivered combined revenues of $40 million in 2023 and provided $6 million in cash generated from operations.
March 5, 2024
·
24 min read
BioMidwest
Inotiv Reaches Agreement to Resolve Previously-Announced Investigation into Shuttered Cumberland Facility
Inotiv Inc. announced that it reached an agreement with the U.S. Department of Justice to resolve a previously-announced criminal investigation into the shuttered canine breeding facility located in Cumberland, Virginia, which was operated originally by Envigo RMS LLC, a company acquired by Inotiv in November 2021.
June 3, 2024
·
5 min read
Business
Cumberland Pharmaceuticals to Announce Third Quarter 2023 Financial Results
Cumberland Pharmaceuticals Inc., a specialty pharmaceuticals company, announced that it will release the third quarter 2023 financial results and provide a company update after the market closes on Tuesday, Nov. 7, 2023.
October 31, 2023
·
2 min read
Cumberland Pharmaceuticals Reports Third Quarter 2023 Financial Results
Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, announced today that its product portfolio of FDA-approved brands delivered combined revenues of $10.1 million during the third quarter of 2023 and $30.2 million year to date.
November 7, 2023
·
24 min read
Business
Cumberland Pharmaceuticals Reports Revenue and Earnings Growth Second Quarter 2023
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, announced significantly improved financial results and a favorable overall company performance for the second quarter of 2023.
August 8, 2023
·
24 min read
Business
Cumberland Pharmaceuticals to Announce Second Quarter 2023 Financial Results
Cumberland Pharmaceuticals Inc., a specialty pharmaceuticals company, announced that it will release the second quarter 2023 financial results and provide a company update after the market closes on Tuesday, Aug. 8, 2023.
August 1, 2023
·
2 min read
Business
Cumberland Pharmaceuticals to Announce First Quarter 2023 Financial Results
Cumberland Pharmaceuticals Inc., a specialty pharmaceuticals company, announced that it will release the first quarter 2023 financial results and provide a company update after the market closes on Tuesday, May 9, 2023.
May 2, 2023
·
2 min read
1 of 70,747
Next
